Novant Health Cancer Institute - Forsyth,2131 S. 17th Street — Wilmington, North Carolina

Novant Health Cancer Institute - Forsyth,2131 S. 17th Street is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Novant Health Cancer Institute - Forsyth,2131 S. 17th Street has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Negative.

Sponsors: Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novant Health Cancer Institute - Forsyth,2131 S. 17th Street?

Novant Health Cancer Institute - Forsyth,2131 S. 17th Street has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novant Health Cancer Institute - Forsyth,2131 S. 17th Street conducted?

Novant Health Cancer Institute - Forsyth,2131 S. 17th Street has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Negative.

Is Novant Health Cancer Institute - Forsyth,2131 S. 17th Street accredited by Crixeo Clinical Trials?

Novant Health Cancer Institute - Forsyth,2131 S. 17th Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novant Health Cancer Institute - Forsyth,2131 S. 17th Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.